InvestorsInvestors News / RNS
- 31 Jan 2012 Physiomics to enter new therapeutic area with appointment of SAB member
- 20 Dec 2011 Issue of Options
- 11 Nov 2011 Physiomics to present on R&D Developments at the 2011 EORTC-NCI-AACR symposium on “Molecular targets and Cancer Therapeutics”
- 18 Nov 2011 Result of AGM
- 09 Nov 2011 Issue of Options
- 02 Nov 2011 Two new projects in support of Lilly's Oncology Programs
- 19 Oct 2011 Physiomics Announces Scientific Advisory Board Re-Structuring
- 11 Oct 2011 Final Results for the year ended 30 June 2011
- 29 Sep 2011 Joint services alliance executed with Jubilant Biosys
- 13 Sep 2011 Collaborative Agreement
- 27 May 2011 Issue of Equity
- 16 May 2011 Issue of Equity
- 04 May 2011 New Collaboration with Pharmacometrics Limited
- 28 Apr 2011 Total Voting Rights
- 06 Apr 2011 Completion of Placement
- 05 Apr 2011 Physiomics to present on Lilly Collaboration at the Annual Meeting for American Association for Cancer Research (“AACR”)
- 01 Apr 2011 Results Update – Virtual Tumour shows improved drug schedule in cancer model
- 29 Mar 2011 Issue of Equity
- 09 Mar 2011 Interim Results
- 08 Mar 2011 Update: Joint services alliance with Jubilant Biosys
- 15 Feb 2011 Share Price Movement
- 09 Feb 2011 Share Price Movement
- 08 Feb 2011 Share Price Movement
- 07 Feb 2011 Issue of Options
- 24 Dec 2010 Director's notification
- 13 Dec 2010 Result of AGM
- 06 Dec 2010 Appointment of an Executive Director
- 16 Nov 2010 Presentation of Virtual Tumour Platform at EORTC-NCI-AACR symposium
- 15 Nov 2010 Carbon Trust Grant
- 15 Nov 2010 Final Results for the year ended 30 June 2010
- 22 Sep 2010 Recent Price Movements
- 31 Aug 2010 Joint Services Alliance with Jubilant Biosys
- 14 May 2010 Recent Price Movements and Press Speculation
- 16 Mar 2010 Collaboration with Sareum, the ICR and CRT
- 01 Mar 2010 Interim Results
- 08 Feb 2010 Holding(s) in Company
- 29 Jan 2010 Total Voting Rights
- 29 Jan 2010 Notice of Interest
- 22 Jan 2010 Issue of Equity
- 29 Dec 2009 Result of AGM
- 18 Dec 2009 Conversion of Loan Note
- 14 Dec 2009 Issue of Equity
- 09 Dec 2009 Holding(s) in Company
- 04 Dec 2009 Issue of Equity
- 30 Nov 2009 Placing of Shares
- 30 Nov 2009 Final Results for the year ended 30 June 2009
- 25 Nov 2009 Holding(s) in Company
- 19 Nov 2009 Holding(s) in Company
- 16 Nov 2009 Holding(s) in Company
- 16 Nov 2009 Physiomics Presentation at AACREORTC-NCI Conference
- 06 Nov 2009 Holding(s) in Company
- 05 Nov 2009 Holding(s) in Company
- 27 Oct 2009 Holding(s) in Company
- 27 Oct 2009 Holding(s) in Company
- 23 Oct 2009 Holding(s) in Company
- 21 Oct 2009 Holding(s) in Company
- 20 Oct 2009 Holding(s) in Company
- 20 Oct 2009 Holding(s) in Company
- 16 Oct 2009 Recent Price Movements
- 01 Oct 2009 Trading Statement
- 18 Sep 2009 Holding(s) in Company
- 11 Sep 2009 Holding(s) in Company
- 08 Sep 2009 Holding(s) in Company
- 03 Sep 2009 Holding(s) in Company
- 28 Aug 2009 Total Voting Rights
- 17 Aug 2009 Holding(s) in Company
- 06 Aug 2009 Conversion of Debt into Equity
- 24 Jul 2009 Holding(s) in Company
- 02 Jul 2009 Holding(s) in Company
- 26 Jun 2009 Holding(s) in Company
- 23 Jun 2009 Update on EC funded TEMPO project – Achievement of Milestone
- 23 Apr 2009 Holding(s) in Company
- 22 Apr 2009 Holding(s) in Company
- 20 Apr 2009 Physiomics Presentation at 100th AACR Conference
- 02 Apr 2009 Physiomics Announces License Agreement with Eli Lilly
- 01 Apr 2009 Change of Nominated Adviser and Broker
- 20 Mar 2009 Holding(s) in Company
- 05 Mar 2009 Holding(s) in Company
- 10 Feb 2009 Interim Results
- 26 Jan 2009 Holding(s) in Company
- 05 Jan 2009 Holding(s) in Company
- 19 Dec 2008 Result of AGM
- 19 Dec 2008 Holding(s) in Company
- 27 Nov 2008 Final Results for the year ended 30 June 2008
- 17 Nov 2008 Physiomics Presentation at Bio-Europe Conference
- 20 Aug 2008 Physiomics to present on Chronotherapy at the International Conference on Systems Biology
- 28 Jul 2008 Trading Statement
- 14 Jul 2008 Physiomics Technology in continued and expanded support of Lilly\'s Oncology Programs
- 20 Jun 2008 Holdings in Company
- 03 Jun 2008 Beyond Genome Presentation
- 20 May 2008 Tempo Project Update
- 22 Apr 2008 Holdings in Company
- 08 Apr 2008 AACR Presentation Update
- 28 Mar 2008 Interim Results
- 15 Feb 2008 Related party loan
- 14 Feb 2008 Management Appointment
- 13 Feb 2008 Physiomics AACR Presentation
- 20 Dec 2007 Board changes
- 17 Dec 2007 MOU with Swansea University (access to Supercomputer “Blue C”)
- 12 Dec 2007 Physiomics Collaboration Update – Cancer Cell Death Model Developed
- 30 Nov 2007 Holdings in Company
- 28 Nov 2007 Notice of Annual General Meeting and Final Results
- 24 Sep 2007 Holdings in Company
- 17 Sep 2007 Holdings in Company
- 17 Sep 2007 Holdings in Company
- 17 Sep 2007 Physiomics Technology in support of Eli Lilly Oncology Program
- 16 Aug 2007 AIM Rule 26 information
- 13 Aug 2007 Holdings in Company
- 07 Aug 2007 Holdings in Company
- 18 May 2007 Appointment of Christophe Chassagnole as Chief Operating Officer
- 16 Mar 2007 Interim Results
- 15 Feb 2007 Agreement announced between ValiRx plc and Physiomics plc
- 02 Jan 2007 Result of Annual General Meeting
- 19 Dec 2006 Total Voting Rights
- 07 Dec 2006 Notice of AGM and prelims
- 28 Nov 2006 Physiomics plc Announces its Participation in the European TEMPO Project
- 07 Nov 2006 Holding(s) in Company
- 29 Sep 2006 Additional Listings
- 28 Sep 2006 EGM Statement
- 01 Sep 2006 Board changes, Placing, Appointment of broker
- 08 Jun 2006 Board changes
- 31 Mar 2006 Interim Results
- 22 Dec 2005 Physiomics Annual General Meeting 2005
- 25 Oct 2005 Major Technical Advance
- 18 Oct 2005 Acquisition of shares by CEO
- 08 Sep 2005 Preliminary results for the period ended 30 June 2005
- 25 Aug 2005 Appointment of David Evans as non-Executive Chairman
- 23 Jun 2005 Physiomics and Bayer launch a new Service
- 21 Mar 2005 Interim Results for 6 months to 31st December 2004
- 23 Dec 2004 UK Patent Registered to Physiomics
- 20 Dec 2004 First Day of Trading on AIM
- 23 Nov 2004 Physiomics and Cronos Therapeutics to develop GeneICE for cancer
- 14 Sep 2004 Bayer Technology Services and Physiomics sign collaboration
- 06 Mar 2003 SMART Award
This part of the website has been designed to comply with the requirements of Rule 26 of the AIM Rules for Companies – 'Company information disclosure' Document Last Updated Tuesday, 13 September 2011
